| J1602 | Injection, golimumab, 1 mg, for intravenous use | 25,450 | $10 | $279.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,770 | $30 | $150K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 3,520 | $30 | $109.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 870 | $110 | $96.1K |
| J0897 | Injection, denosumab, 1 mg | 4,500 | $20 | $81K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 390 | $120 | $48.6K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 400 | $30 | $10.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 150 | $60 | $8.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $150 | $7.7K |
| 20611 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe… | 60 | $100 | $5.5K |